Fulton Bank Has Cut Its Abbvie (ABBV) Holding; Knightsbridge Asset Management Raised Its Bank Amer (BAC) Position

Fulton Bank decreased Abbvie Inc (ABBV) stake by 9.83% reported in 2017Q3 SEC filing. Fulton Bank sold 8,108 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Fulton Bank holds 74,376 shares with $6.61 million value, down from 82,484 last quarter. Abbvie Inc now has $182.68 billion valuation. The stock increased 1.05% or $1.2 during the last trading session, reaching $115.04. About 5.44M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since March 5, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Knightsbridge Asset Management Llc increased Bank Amer Corp (BAC) stake by 19.55% reported in 2017Q3 SEC filing. Knightsbridge Asset Management Llc acquired 62,487 shares as Bank Amer Corp (BAC)’s stock declined 6.00%. The Knightsbridge Asset Management Llc holds 382,153 shares with $9.68 million value, up from 319,666 last quarter. Bank Amer Corp now has $324.01 billion valuation. The stock increased 0.48% or $0.15 during the last trading session, reaching $31.63. About 82.74 million shares traded or 10.42% up from the average. Bank of America Corporation (NYSE:BAC) has risen 58.64% since March 5, 2017 and is uptrending. It has outperformed by 41.94% the S&P500.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc has $150.0 highest and $6 lowest target. $93.33’s average target is -18.87% below currents $115.04 stock price. Abbvie Inc had 79 analyst reports since July 21, 2015 according to SRatingsIntel. Barclays Capital maintained AbbVie Inc. (NYSE:ABBV) on Friday, October 13 with “Equal-Weight” rating. The firm has “Buy” rating given on Friday, September 15 by Piper Jaffray. The firm earned “Hold” rating on Wednesday, June 7 by BMO Capital Markets. Jefferies maintained AbbVie Inc. (NYSE:ABBV) rating on Monday, July 17. Jefferies has “Buy” rating and $94 target. On Sunday, October 29 the stock rating was maintained by SunTrust with “Buy”. The firm has “Buy” rating by Piper Jaffray given on Thursday, September 28. Barclays Capital downgraded the shares of ABBV in report on Tuesday, December 1 to “Equal-Weight” rating. The firm has “Hold” rating given on Friday, April 28 by BMO Capital Markets. The firm earned “Neutral” rating on Thursday, September 8 by JP Morgan. UBS downgraded AbbVie Inc. (NYSE:ABBV) on Monday, September 25 to “Neutral” rating.

Since September 11, 2017, it had 0 buys, and 6 insider sales for $25.71 million activity. $119,351 worth of AbbVie Inc. (NYSE:ABBV) was sold by Michael Robert A. on Monday, February 19. Another trade for 8,300 shares valued at $705,655 was made by SALEKI-GERHARDT AZITA on Monday, September 11. Schumacher Laura J sold $14.07 million worth of stock or 145,510 shares. RICHMOND TIMOTHY J. also sold $8.57 million worth of AbbVie Inc. (NYSE:ABBV) shares. 18,300 shares were sold by Gosebruch Henry O, worth $1.66 million on Monday, October 30.

Fulton Bank increased Chevron Corp New (NYSE:CVX) stake by 4,831 shares to 50,136 valued at $5.89M in 2017Q3. It also upped Harding Loevner Fds Inc stake by 16,792 shares and now owns 147,644 shares. Baron Select Funds was raised too.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Salem Capital Management Inc, a Massachusetts-based fund reported 11,700 shares. Shelton Management holds 127,799 shares or 0.88% of its portfolio. Yacktman Asset LP has 2,800 shares for 0% of their portfolio. Oakbrook, Illinois-based fund reported 27,957 shares. Sabal Trust accumulated 3.07% or 345,442 shares. Wms Ptnrs Limited Liability Corp has invested 0.1% of its portfolio in AbbVie Inc. (NYSE:ABBV). Pictet Asset Management Ltd has 0.32% invested in AbbVie Inc. (NYSE:ABBV) for 1.29 million shares. Berkshire Asset Management Ltd Company Pa owns 2.96% invested in AbbVie Inc. (NYSE:ABBV) for 299,024 shares. 6,691 are held by Bangor Bank & Trust. Moreover, Finance Counselors has 1.1% invested in AbbVie Inc. (NYSE:ABBV) for 253,354 shares. Wolverine Asset Mgmt Ltd reported 0.06% in AbbVie Inc. (NYSE:ABBV). Wealthtrust Axiom Limited Liability owns 4,307 shares for 0.15% of their portfolio. Columbia Asset Mngmt owns 30,420 shares. Independence Tru holds 2.65% or 26,133 shares. Mirae Asset Global Invests Communication Limited stated it has 98,056 shares or 0.16% of all its holdings.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26. They expect $1.78 EPS, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.83B for 16.16 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Among 33 analysts covering Bank of America (NYSE:BAC), 22 have Buy rating, 0 Sell and 11 Hold. Therefore 67% are positive. Bank of America has $37 highest and $15 lowest target. $26.24’s average target is -17.04% below currents $31.63 stock price. Bank of America had 106 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Robert W. Baird given on Wednesday, November 16. Keefe Bruyette & Woods upgraded the shares of BAC in report on Tuesday, November 29 to “Outperform” rating. The stock of Bank of America Corporation (NYSE:BAC) earned “Buy” rating by Vetr on Tuesday, August 11. Renaissance Macro Securities LLC maintained Bank of America Corporation (NYSE:BAC) on Sunday, July 23 with “Buy” rating. The stock of Bank of America Corporation (NYSE:BAC) earned “Outperform” rating by KBW on Monday, August 24. The rating was upgraded by Atlantic Securities on Wednesday, December 21 to “Overweight”. Oppenheimer maintained Bank of America Corporation (NYSE:BAC) on Saturday, September 5 with “Outperform” rating. Jefferies maintained it with “Buy” rating and $2800 target in Friday, July 7 report. The firm earned “Hold” rating on Tuesday, September 13 by Societe Generale. The stock of Bank of America Corporation (NYSE:BAC) has “Neutral” rating given on Wednesday, January 11 by UBS.

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.08, from 1.12 in 2017Q2. It dived, as 68 investors sold BAC shares while 569 reduced holdings. 117 funds opened positions while 547 raised stakes. 6.91 billion shares or 9.01% more from 6.34 billion shares in 2017Q2 were reported. 740,458 were reported by Tdam Usa Inc. The Iowa-based Cambridge Research Advsr has invested 0.28% in Bank of America Corporation (NYSE:BAC). Aimz Invest Advsrs Ltd reported 0.48% in Bank of America Corporation (NYSE:BAC). Cypress Cap Mgmt Llc (Wy) holds 4,871 shares. Sanders Cap Lc holds 29.89 million shares. Columbia Asset Management stated it has 61,446 shares or 0.48% of all its holdings. Gendell Jeffrey L owns 2.58M shares or 5.23% of their US portfolio. Twin Capital Mngmt invested in 1.46% or 1.10M shares. Orrstown Inc reported 2,366 shares or 0.07% of all its holdings. Moody National Bank & Trust Trust Division owns 0.06% invested in Bank of America Corporation (NYSE:BAC) for 50,158 shares. Meiji Yasuda Life Com invested in 0.85% or 227,769 shares. Diversified Invest Strategies Limited Company invested 0.36% of its portfolio in Bank of America Corporation (NYSE:BAC). Vantage Invest Ptnrs Ltd Llc holds 1.68 million shares. Cumberland Ptnrs Ltd invested in 1.82% or 534,175 shares. Budros Ruhlin And Roe has invested 0.13% in Bank of America Corporation (NYSE:BAC).